Search the Newsreel

Die Bristol-Myers-Squibb-Aktie legt nach starken Quartalszahlen zu

Ribbon Attends Two Investor Conferences in August

Ribbon Communications Inc. (Nasdaq: RBBN) announced its attendance at two investor conferences in August 2026. The company will participate in the Rosenblatt 6th Annual Tech Summit on August 17-18 and the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25. Ribbon is …

BBB Foods Inc (TBBB) (Q2 2026) Earnings Call Highlights: Revenue Surges 39% and Same-Store ...

This article first appeared on GuruFocus. Total Revenue: MXN 26 billion, up 39% year-over-year. Same-Store Sales: Increased 20% compared to the second quarter of 2025. EBITDA (Reported): MXN 960 million. EBITDA (Excluding Non-Cash Share-Based Compensation): Increased 44% to MXN 1.6 billion. Adjusted EBITDA Margin: …

Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?

On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott's non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic …

2 Reasons to Like ABBV and 1 to Stay Skeptical

2 Reasons to Like ABBV and 1 to Stay Skeptical AbbVie has followed the market's trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.7% to $249.64 per share while the index has gained …

Should Zacks’ Strong Buy Call on Pebblebrook Hotel Trust (PEB) Require Action From Investors?

BBB Foods (TBBB) Stock Retreats As Losses Deepen Despite 20% Same Store Growth

BBB Foods (TBBB) stock fell about 3% after its Q2 2026 earnings report, despite a 20% growth in same-store sales and a 20% increase in revenue. The company reported a deeper net loss of MXN 386.3m, compared to MXN 286.1m in the previous year, …

Blackberry Stock Price Forecast. Should You Buy BB?

StockInvest.us rates BlackBerry Limited (BB) as a Sell Candidate with a technical score of -1.56, unchanged from its previous evaluation. Despite a 5.70% price increase since a sell signal on July 27, 2026, and a predicted 6.96% rise over the next three months, the …

Royal Caribbean Cruises Ltd (RCL) Stock News Today

Chubb Ltd To Go Ex-Dividend On September 11th, 2026 With 1.02 USD Dividend Per Share

Chubb Ltd (NYSE:CB) is scheduled to go ex-dividend on September 11th, 2026. Shareholders recorded on this date will be eligible to receive a dividend of 1.02 USD per share. This indicates a key upcoming event for investors in Chubb Ltd.

AbbVie Inc. SEC Filing (Aug 14, 2026)

This article details an AbbVie Inc. (ABBV) SEC Form 144 filing from August 14, 2026, indicating a proposed sale of 32,710 shares worth $8,177,500.00 by an individual who acquired them through a stock option exercise on the same date. The filing, accepted by the …

Royal Caribbean Group stock underperforms Friday when compared to competitors

Royal Caribbean Group (RCL) stock fell by 1.57% on Friday, closing at $305.00, despite a two-day winning streak. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also declining. …

AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Ribbon Acquisition Corp. (RIBB) earns $233K but warns of going concern risk

Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma

Bristol Myers Squibb's drug, iberdomide (Zenbexus), has received accelerated FDA approval for treating multiple myeloma, making it the first FDA-approved cereblon-modulating (CELMoD) protein degrader. Zenbexus is indicated for use with Darzalex Faspro and dexamethasone in adults who have received at least one prior line …

Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing …

Riverview Rubber Estates, Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

American Century entities (GT) disclose 5%+ beneficial ownership in Goodyear stock

American Century entities, including American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, have disclosed beneficial ownership of over 5% of Goodyear Tire & Rubber Company common stock. The American Century ETF Trust …

Die AbbVie-Aktie legt nach starkem Q2-2026-Bericht und angehobener Prognose zu

Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?

AbbVie's neuroscience franchise experienced strong growth in the first half of 2026, with sales reaching $6.1 billion, driven by key drugs like Vraylar, Ubrelvy, Qulipta, and Botox Therapeutic, and the rapid uptake of Vyalev. The company anticipates further growth from the potential approval of …

BBB Foods Inc. (TBBB): Orbis-led investors disclose 8.6% ownership position

Goodyear (GT) Is Down 8.6% After Q2 Loss And Plant Closure Plan Has The Bull Case Changed?

Goodyear Tire & Rubber reported a significant Q2 2026 loss of US$204 million, a downturn from a profit of US$254 million a year prior, with sales dropping to US$4,250 million. This performance, coupled with a plant closure plan, raises concerns about the company's earnings …

BBB Foods (TBBB): Quilvest group reports 3.5% beneficial stake via Class C shares

The Quilvest group, through various investment entities, has reported a 3.5% beneficial ownership stake in BBB Foods Inc. (TBBB) via Class C Common Shares. As of June 30, 2026, the group held 2,299,502 Class C shares, which are treated as convertible into Class A …

Die Abbott-Laboratories-Aktie legt nach starker Q2-Guidance moderat zu

The Bull Case For Royal Caribbean Cruises (RCL) Could Change Following New 2034 Bond Sale And Profit Upgrade

Royal Caribbean Cruises (RCL) recently issued US$1.25 billion in 2034 senior unsecured notes shortly after raising its full-year profit outlook due to strong demand. This move indicates the company's willingness to use debt markets to fund growth, reinforcing the importance of sustained cruising appeal …

Bristol Myers Squibb stock gains support from new multiple myeloma approval and raised earnings fore

Die Bristol-Myers-Squibb-Aktie profitiert von FDA-Zulassung und solider Prognose

Abbott Laboratories: Revenue and Earnings Analysts Forecasts Revisions | ABT | US0028241000

Ribbon Communications to attend major tech and semiconductor conferences in August 2026

Ribbon Communications announced its participation in two major industry events in August 2026: the Rosenblatt 6th Annual Tech Summit on AI and the Jefferies Semiconductor, IT Hardware & Communications Technology Conference. The company aims to highlight its advancements in autonomous networks, leveraging AI and …

TBBB Crosses Above Average Analyst Target

In recent trading, shares of BBB Foods Inc (Symbol: TBBB) have crossed above the average analyst 12-month target price of $43.80, changing hands for $49.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade …

Die Bristol-Myers-Squibb-Aktie legt nach starken Q2-Zahlen und neuer Zahlung zu

Two August tech conferences put Ribbon on the calendar for investors

Ribbon Communications (Nasdaq: RBBN) announced its participation in two investor conferences in August 2026: the Rosenblatt 6th Annual Tech Summit on August 17-18 and the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25. The company, a global leader in communications technology, …

BMS welcomes new multiple myeloma drug as generics batter current portfolio

Bristol Myers Squibb (BMS) received accelerated FDA approval for Zenbexus (iberdomide) for multiple myeloma, offering a new revenue stream as generics severely impact sales of its existing drugs, Revlimid and Pomalyst. Zenbexus is projected to achieve over $1 billion in annual earnings by 2031, …

BBB Foods Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:TBBB) 2026-08-14

Hubbell (HUBB) Is Quietly Winning From AI Infrastructure Growth

Parnassus Investments, an investment management company, released the "Parnassus Core Equity Fund" second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500's 15.20% gain. Performance …

Thomasville National Bank Buys Shares of 26,575 AbbVie Inc. $ABBV

Thomasville National Bank acquired a new stake of 26,575 shares in AbbVie Inc., valued at approximately $6.687 million, during the second quarter. AbbVie continues to show strong institutional interest, positive analyst sentiment with a "Moderate Buy" consensus and an average price target of $275.50, …